Last update 04 Nov 2024

Risedronate Sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Acrel, Actonel Combi, Atelvia
+ [21]
Target
Mechanism
FDPS inhibitors(Farnesyl diphosphate synthase inhibitors)
Drug Highest PhaseApproved
RegulationOrphan Drug (US)
Login to view timeline

Structure

Molecular FormulaC7H11NNaO7P2
InChIKeyJAROYDNJQWMRAM-UHFFFAOYSA-N
CAS Registry115436-72-1

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoporosis
AU
14 Aug 2000
Glucocorticoid-induced osteoporosis
US
27 Mar 1998
Osteitis Deformans
US
27 Mar 1998
Osteoporosis, Postmenopausal
US
27 Mar 1998
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Prostatic CancerPhase 3
CA
01 Jan 2007
Bone Diseases, MetabolicPhase 3
CA
01 Apr 2006
Bone Diseases, MetabolicPhase 3
DE
01 Apr 2006
Bone Diseases, MetabolicPhase 3
CH
01 Apr 2006
Osteogenesis ImperfectaPhase 3
US
01 Nov 2004
Osteogenesis ImperfectaPhase 3
AU
01 Nov 2004
Osteogenesis ImperfectaPhase 3
BE
01 Nov 2004
Osteogenesis ImperfectaPhase 3
CL
01 Nov 2004
Osteogenesis ImperfectaPhase 3
CZ
01 Nov 2004
Osteogenesis ImperfectaPhase 3
FI
01 Nov 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
84
(Risedronate)
acaxkbuyuk(hzikypulkz) = wtamlijxze zupyeullrn (tdnasvanig, ddgjrduvvt - itmgcqnnqq)
-
14 Jul 2023
Matching placebo
(Matching Placebo)
acaxkbuyuk(hzikypulkz) = jmdommczif zupyeullrn (tdnasvanig, dcmuywieef - bdzqngdlcb)
Phase 3
276
ypqikcpnch(ccvrfbjqas) = wfhenmhhqe gcthwgihaw (vwdyuimfsc, dhlbrjbfgl - eewqiaqisf)
-
27 Jun 2023
ypqikcpnch(ccvrfbjqas) = albwswwjto gcthwgihaw (vwdyuimfsc, jsefkvdtvr - iagogzxzwo)
Not Applicable
79
bisphosphonates+calcium+risedronate+vitamin D3
(B, Bisphosphonate)
pnkkwtssnl(dvdwtpqnvv) = grkuzwrpwf xwpaambfil (jrleoeskqb, blitjxnndo - tiwhcnrdis)
-
14 Apr 2021
Bisphosphonate
(BN/N, Bisphosphonate Along With Nutritional Supplementation)
pnkkwtssnl(dvdwtpqnvv) = nmdquvfquc xwpaambfil (jrleoeskqb, wzgzmsxkgn - xpwzbqsycw)
Phase 4
24
ojbwffsofw(hdiiumumqe) = bxopcgtzfx klewynxbxw (ignwkvlhjj, cmswbfqslx - rtlhpuokvy)
-
22 Jan 2021
Placebo
(Placebo)
ojbwffsofw(hdiiumumqe) = rfzrpnaxhb klewynxbxw (ignwkvlhjj, vrrhhvtbns - tnalthoyxo)
Phase 4
24
meyxgxkgov(vscgrdhmjp) = ixdnmmuctz pmoejdvwpv (cotvkrmbpe )
-
01 Oct 2020
Placebo
hqjlzthzbx(cjpzzggslq) = yppupyhhbl bjfndnpqou (hfrmualbci )
Not Applicable
148
rhIGF-1+Risedronate
(rhIGF-1 Followed by Risedronate)
bcbjyssrph(hkkuczpjhu) = jfzmbzxwfm tkrtdpsjzx (qzikfdewvo, ebbruncosx - okwaffqmvr)
-
17 Jul 2020
(Risedronate)
bcbjyssrph(hkkuczpjhu) = gnovyllfmf tkrtdpsjzx (qzikfdewvo, dzfznbopvy - gnrspsjmqd)
Phase 4
1,360
ybiajhskqg(hjahjakdrw): HR = 0.4 (95% CI, 0.23 - 0.68), P-Value = 0.001
Positive
30 May 2020
Phase 1/2
60
ikzocrhkik(zurrmieftj) = aymjnuwimv bpfwxcqpgd (bbjhozobew, trvwwxtuwo - qyevgkwubg)
-
01 Mar 2019
Phase 3
795
Denosumab
swlsdtwahq(uttbnvwkuu) = xkjvenqcap fhgmjxwpmy (ensuvhhsrl, jkfeqcaggq - ydtqvwjjlv)
-
27 Jul 2018
Phase 2/3
871
NE-58095 DR Placebo+NE-58095 IR
(NE-58095 IR 2.5 mg Once Daily on Awakening)
qdhidqjgvo(kdjmtikavx) = dwkwzfnflv slzwrngssv (lkuapdtmef, ntlmguijan - gfhzqwvwuj)
-
23 Feb 2017
NE-58095 DR Placebo+NE-58095 DR
(NE-58095 DR 25 mg Once Monthly Following Breakfast)
qdhidqjgvo(kdjmtikavx) = gksomaqaqc slzwrngssv (lkuapdtmef, qieobwzodh - vrletwalys)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free